
Epicrispr Biotechnologies
- Epicrispr Biotechnologies just raised $90M (Series C) on Aug 10
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
About
Epicrispr Biotechnologies is a clinical-stage biotechnology company pioneering gene-modulating therapies. They are focused on developing a new class of programmable epigenetic medicines designed to durably regulate gene expression without permanently altering the underlying DNA sequence. Their lead program, EPI-321, is in clinical trials for Facioscapulohumeral Muscular Dystrophy (FSHD).
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Drug Discovery
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Biotech
A vertically-integrated procurement platform for the life sciences industry.
Shares Biotechnology, Biotech
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Epicrispr Biotechnologies?
People comparing tools land here. Get listed beside these.
Copy Epicrispr Biotechnologies's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- epicrispr.com
- Headquarters
- South San Francisco, United States
- Founded
- 2020
- Founder
- Lei Stanley Qi
- Employees
- 51
- Total funding
- $90M (Series C)
- Business model
- B2B
Funding rounds
- $90M10 Aug 2026
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Aug 2026 | Series C | $90M |
Tech stack
Detected on epicrispr.com, last scanned 13 Nov 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Email marketing
- Mailchimp
Benchmarking
See how your site ranks against 16,849 startups
Epicrispr Biotechnologies sits in the 48th percentile for Domain Rating. Check where yours lands, free.
Epicrispr Biotechnologies has a Domain Rating of 39, the 48th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursEffective DR
Bottom 25%
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Below median
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Epicrispr Biotechnologies scores 39. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Epicrispr Biotechnologies changes
Used Epicrispr Biotechnologies? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
How people find Epicrispr Biotechnologies on Google
Searches that showed this page, last 28 days
- epic bio$$$1 seen#87
- epicrispr$$$1 seen#8
- epicrispr biotechnologies$$$1 seen#66
$$$ high buyer intent (pricing, reviews, alternatives), $$ brand searches, $ research. Read from the wording, not ad prices.
Frequently asked
Is Epicrispr Biotechnologies growing?
Yes, fast. Our data shows it raised $90M in a Series C in August 2026.
Are there companies like Epicrispr Biotechnologies?
Yes. We list 6 companies like Epicrispr Biotechnologies, including Moderna, Degron Therapeutics and Pixelgen Technologies. Epicrispr Biotechnologies has raised more than 4 of the 6 with funding on record.
Is Epicrispr Biotechnologies trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Epicrispr Biotechnologies is 71 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Epicrispr Biotechnologies raised?
Epicrispr Biotechnologies has raised a total of $90M in funding. The most recent round on record is Series C.
How many employees does Epicrispr Biotechnologies have?
Epicrispr Biotechnologies has approximately 51 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Epicrispr Biotechnologies:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Epicrispr Biotechnologies and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


